Genfit SA
PAR:GNFT
Genfit SA
Intangible Assets
Genfit SA
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
Genfit SA
PAR:GNFT
|
Intangible Assets
€50.3m
|
CAGR 3-Years
597%
|
CAGR 5-Years
124%
|
CAGR 10-Years
86%
|
|
|
Valneva SE
PAR:VLA
|
Intangible Assets
€23.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Inventiva SA
PAR:IVA
|
Intangible Assets
€85k
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
N/A
|
|
|
DBV Technologies SA
PAR:DBV
|
Intangible Assets
$26k
|
CAGR 3-Years
23%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Abivax SA
PAR:ABVX
|
Intangible Assets
€6.6m
|
CAGR 3-Years
304%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sensorion SA
PAR:ALSEN
|
Intangible Assets
€946k
|
CAGR 3-Years
20%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
Genfit SA
Glance View
Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The company is headquartered in Loos, Hauts-De-France. The company went IPO on 2006-12-19. The firm is focused on contributing to bringing medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases that affect the liver, such as Nonalcoholic steatohepatitis (NASH) or the bowel, such as the inflammatory bowel disease. The firm targets a number of therapeutic areas, which includes nonalcoholic steatohepatitis (NASH), primary biliary cholangitis (PBC), NASH diagnosis, NASH-induced fibrosis and IL-17 dependent autoimmune diseases. The Company’s research programs develop diversified pipeline of drug candidates, including Elafibranor in NASH, which is in phase III; Elafibranor in PBC, which is in phase II; In-Vitro diagnostic test for NASH and Nitazoxanide in fibrosis, which is still in clinical stage, among others.
See Also
What is Genfit SA's Intangible Assets?
Intangible Assets
50.3m
EUR
Based on the financial report for Jun 30, 2025, Genfit SA's Intangible Assets amounts to 50.3m EUR.
What is Genfit SA's Intangible Assets growth rate?
Intangible Assets CAGR 10Y
86%
Over the last year, the Intangible Assets growth was 7%. The average annual Intangible Assets growth rates for Genfit SA have been 597% over the past three years , 124% over the past five years , and 86% over the past ten years .
